Ivy Fowler

Executive Director Operational Strategy

A 20 year veteran of global life cycle clinical development and project delivery, including data management, safety, regulatory, clinical trial management, with executive program oversight. Most notably, Ms. Fowler was responsible for the global delivery of the REDUCE Trial, which assessed the use of Avodart™​ (a 5ARI) in reducing the risk of Prostate Cancer in men considered to be at risk for the disease. The Avodart prostate cancer program included more than 850 study centers in 42 countries and involved more than 8000 men.

Additional Information